In fact, CD200 is particularly helpful in distinguishing some disease entities, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), whose clinical behavior and prognosis is quite different [3,4,5]. This evidence concerns the gene CD200 and B-cell chronic lymphocytic leukemia.